A Phase 2, Open-Label Dose-Finding Study to Evaluate the

Project: Research project

Project Details

Description

A Phase 2, Open-Label Dose-Finding Study to Evaluate the Safety, Efficacy, and Tolerability of Multiple Subcutaneous Doses of rAvPAL-PEG in Subjects with PKU" and "Long-term Extension of a Phase 2, Open-Label Dose-Finding Study to Evaluate the Safety, E
StatusFinished
Effective start/end date4/6/0912/31/14

Funding

  • BIOMARIN PHARMACEUTICAL, INC.

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.